Nirvana Life Sciences Inc.
NIRVF
$0.083
$0.0830.00%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -82.61% | -94.20% | -93.65% | -84.78% | -28.13% |
| Total Receivables | -0.72% | -23.60% | -21.26% | 10.57% | 36.63% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -73.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -61.48% | -68.54% | -77.57% | -70.36% | -58.97% |
|
|
|||||
| Total Current Assets | -61.48% | -68.54% | -77.57% | -70.36% | -58.97% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -91.09% | 215.73% | -77.57% | -70.36% | -46.27% |
|
|
|||||
| Total Accounts Payable | -32.23% | 7.75% | 24.17% | 6.64% | -31.67% |
| Total Accrued Expenses | 22.95% | 38.90% | 36.75% | 19.83% | 35.45% |
| Short-term Debt | 279.66% | 217.95% | 298.36% | -52.20% | -71.59% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 0.00% | -3.85% | -1.96% | 0.00% |
| Total Other Current Liabilities | -- | 0.00% | -3.85% | -1.96% | 0.00% |
| Total Current Liabilities | 19.42% | 38.01% | 36.74% | 13.31% | 8.97% |
|
|
|||||
| Total Current Liabilities | 19.42% | 38.01% | 36.74% | 13.31% | 8.97% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 279.66% | 217.95% | 298.36% | -52.20% | -71.59% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.78% | 57.04% | 36.98% | 13.31% | 8.97% |
|
|
|||||
| Common Stock & APIC | -7.56% | -0.33% | -4.77% | 7.07% | 8.17% |
| Retained Earnings | 1.48% | -5.21% | -1.89% | -9.78% | -17.07% |
| Treasury Stock & Other | -2.74% | 13.51% | 23.24% | 29.36% | 372.09% |
| Total Common Equity | -51.22% | -45.63% | -51.18% | -19.32% | -48.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -51.22% | -45.63% | -51.18% | -19.32% | -48.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -14.29% | -25.81% | -23.33% | -44.00% | -250.00% |
| Total Equity | -51.02% | -45.53% | -51.03% | -19.42% | -48.59% |
|
|
|||||